Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10092150
Abstract: Systemic sclerosis (SSc) is a rare connective tissue disorder characterized by immune dysregulation evoking the pathophysiological triad of inflammation, fibrosis and vasculopathy. In SSc, several alterations in the B-cell compartment have been described, leading to… read more here.
Keywords: therapeutic target; systemic sclerosis; target systemic; sclerosis ... See more keywords
α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12030396
Abstract: Systemic sclerosis is a connective tissue disease of unknown origin that is characterized by immune system abnormalities, vascular damage, and extensive fibrosis of the skin and visceral organs. α2-antiplasmin is known to be the main… read more here.
Keywords: systemic sclerosis; sclerosis; target systemic; potential therapeutic ... See more keywords